- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04622176
Magnetomotoric Ultrasound for Diagnostic Purposes in Rectal Cancer (MMURC)
December 7, 2023 updated by: Eva Angenete, Sahlgrenska University Hospital, Sweden
A magnetomotive ultrasound combines standard diagnostic ultrasound equipment with the application of an external time-varying magnetic field.
The investigators aim to use this equipment to improve preoperative diagnostics in rectal cancer.
Study Overview
Detailed Description
The investigators will compare magnetomotive ultrasound with MRI and pathology report on specimens extracted during surgery.
Study Type
Observational
Enrollment (Estimated)
28
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eva Angenete, MD. PhD
- Phone Number: +46760-514441
- Email: eva.angenete@vgregion.se
Study Locations
-
-
-
Gothenburg, Sweden, SE 416 85
- Recruiting
- Dept. of Surgery, Sahlgrenska University Hospital/Ostra
-
Contact:
- Erik
-
Contact:
- Eva Angenete, MD,PhD
- Phone Number: +46313438410
- Email: eva.angenete@vgregion.se
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Patients with rectal cancer undergoing abdominoperineal excision.
Description
Inclusion Criteria:
- Rectal cancer
- Surgery with abdominoperineal resection
Exclusion Criteria:
- No informed consent
- Not fulfilling inclusion criteria
- No rectal cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients with rectal cancer
Patients with rectal cancer will be included and asked to participate in the study where a MMUS will be used after resection to test diagnostic accuracy.
|
MMUS will be used to perform diagnostics, we will compare with MRI and histology
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of lymph node diagnosis compared to pathology report
Time Frame: 1 hour postoperatively
|
Accuracy of lymph node diagnosis - a comparison between the findings with the device and the pathology report
|
1 hour postoperatively
|
|
Accuracy of lymph node diagnosis compared to MRI
Time Frame: 1 hour postoperatively
|
Accuracy of lymph node diagnosis compared to MRI
|
1 hour postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Eva Angenete, Sahlgrenska Universitetssjukhuset
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 17, 2021
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
October 23, 2020
First Submitted That Met QC Criteria
November 6, 2020
First Posted (Actual)
November 9, 2020
Study Record Updates
Last Update Posted (Actual)
December 8, 2023
Last Update Submitted That Met QC Criteria
December 7, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MMURC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.